Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT05446961

Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus

COVID-19 Virus Infection Clinical Trial

Official title:
Pilot Phase II Randomized, Placebo-Controlled Clinical Trial for the Prevention and Progression of SARS-CoV-2 Infection of Subjects and Patients Using a Supplement Treatment With Carnipure Tartrate ( LCLT)

Clinical Trial Summary

The purpose of the study is to assess safety and efficacy of Carnipure tartrate (L-Carnitine and L-tartaric acid - LCLT) supplementation for SARS-Cov-2 infection

Clinical Trial Description

After being informed about the study and potential risks, all patients given written informed consent will be divided em two cohorts according to inclusion criteria.One group with patients with diagnosed mild SARS-Cov-2 infection and another with healthy contacts of patients with diagnosed mild SARS-Cov-2. Both groups will be randomized to receive either LCLT supplementation or placebo during 21 days. After this period primary endpoints of efficacy will be assessed. Clinical follow up evaluations will be monitored (Cohort 1 and 2), and chest tomography will be monitored in cohort 2 as well. Subjects will be followed for safety through 8 weeks (cohort 1) and 6 weeks (cohort 2) after being included into the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05446961
Study type Interventional
Source SENAI CIMATEC
Contact
Status Completed
Phase Phase 2
Start date March 1, 2021
Completion date February 3, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT04560881 - Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) Phase 3
Terminated NCT04449380 - Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients Phase 2
Active, not recruiting NCT05208983 - SafeTy and Efficacy of Preventative CoVID Vaccines
Completed NCT05364268 - Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation
Completed NCT05268679 - Covid-19 Vaccine Response in Heart Transplant Recipients
Terminated NCT04847583 - A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients Phase 2
Terminated NCT04778059 - Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 Phase 2
Terminated NCT04786808 - Risk Factors for COVID-19 Mortality
Completed NCT05514691 - Evaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POC N/A
Withdrawn NCT05085574 - Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1) Phase 2
Completed NCT05489367 - Does COVİD-19 m-RNA Vaccine Affect Fertility and Over Reserve ?
Withdrawn NCT05133635 - High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19 Phase 4
Active, not recruiting NCT05077332 - LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) Phase 2
Terminated NCT05077969 - Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) Phase 2
Completed NCT05371561 - Effect of PPE on Children's Fear in Dental Office N/A